Atrial fibrillation is of the most frequently occurred arrhythmia that causes problem with the rhythm of the heart (such as too slow or too fast heart beat). During atrial fibrillation, heart beats are irregular and it can be too slow or too fast as compared to the regular heartbeat. Atrial fibrillation can increase the rate of heart stroke, cause chest pain or even heart attack especially if the heart beat is too fast. During atrial fibrillation, both the chambers (upper and lower) beat irregularly, chaotically, and out of coordination of the heart. Shortness of breath, weakness, chest pain, dizziness, lightheadedness or fainting and heart palpitation are the common symptoms of atrial fibrillation. In addition, atrial fibrillation may lead to formation of blood clots in the heart, which may circulate to other organs. In atrial fibrillation, for altering the electrical system of heart, treatments such as medications and interventions are provided.
Atrial fibrillation market is in its emerging state as the prevalence of atrial fibrillation is growing rapidly along with the increase in aging population. According to American Heart Association, 33.5 million individuals (0.5% of the world’s population) were with atrial fibrillation in 2013. Also, technological advancement towards surgical devices for atrial fibrillation fuels the market growth. However, pitfalls such as stringent government policies, high cost of atrial fibrillation treatment, and dearth of skilled professionals and technicians hinders the market growth.
The world atrial fibrillation market has been segmented based on devices and region. Based on devices, the market is segmented into surgical devices and non-surgical devices. Surgical devices are further sub-classified into maze surgery and catheter ablation. Non-surgical devices are further sub-divided into electric cardioversion, diagnostic catheters, mapping and recording systems, cardiac monitors, access devices, left atrial appendage, and closure devices and intracardiac echocardiography (ICE) Systems. The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
The key strategies adopted are product launch, collaboration, and merger & acquisition. For instance, Abbott acquired Kalila Medical, Inc. (U.S.), which helped Abbott develop next generation technologies that are useful to treat cardiac disorders such as atrial fibrillation. Biosense Webster, Inc. acquired Coherex Medical, Inc. (U.S.), which helped Biosense Webster, Inc. to strengthen its medical devices product portfolio.
KEY MARKET BENEFITS:
KEY MARKET SEGMENT:
Other players in the value chain include
*Profiles of these players are not included. The same will be included on request.
SIMILAR MARKET STUDIES
Summary Insight Genetics, Inc. (Insight Genetics) is a molecular diagnostics company. It focuses on the discovery, development and commercialization of companion diagnostics. The company specializes in the diagnosis, monitoring and treatment of cancer. Insight Genetics, through its lab provides cancer testing services mainly to oncologists and pharmaceutical companies. The pipeline portfolio ...
May 2014 | $750 | View Details >>
About intravenous access devices Intravenous access devices are used for the rapid delivery of nutrients, fluids, and drugs such as antibiotics, analgesics, and antipyretics to a patient. It is also used for blood transfusion and the correction of electrolyte imbalance. Intravenous access devices include central venous catheters and peripheral intravenous catheters. Technavio's ...
November 2015 | $2500 | View Details >>
Summary ReShape Medical, Inc. (ReShape Medical) is a medical device company. The company manufactures products for weight loss. Its ReShape Duo is a non surgical dual-intragastric balloon, which is used in the treatment of obese or overweight patients. ReShape Medicals product is inserted through the mouth into the stomach. The company ...
April 2015 | $250 | View Details >>
Summary Ethicon Endo-Surgery, Inc. (Ethicon) is a medical equipment company. It develops and markets surgical instruments and devices. Its major products include sutures, staplers, energy devices, clip appliers, trocars and meshes. Its products are used in minimally invasive and open surgical procedures to treat colorectal, thoracic, and womens health conditions, hernias, ...
July 2015 | $250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research